| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |